Abstract:Background: Irritable bowel syndrome-diarrhoea (IBS-D) and IBS-mixed stool pattern (IBS-M) are disorders of gut-brain interaction characterised by abdominal pain associated with diarrhoea or both diarrhoea and constipation respectively. The pathophysiology of IBS-D/M is multifactorial and not completely understood; thus, treatment is aimed at multiple mechanisms such as altering gut microbiota, visceral hypersensitivity, intestinal permeability, gut-brain interaction and psychological strategies. Aim: The goal of this article was to provide an up-to-date review of the current evidence for both non-pharmacological and pharmacological treatment options in IBS-D and IBS-M. Future treatments for IBS-D and IBS-M will also be discussed. Methods: Medline and Embase database searches (through April 30 2021) to identify clinical studies in subjects with IBS-D in which dietary modification, alternative treatments (probiotics, acupuncture, exercise) as well as FDA-approved medications were used. Results: Dietary modification is often the first line of therapy. Furthermore, lifestyle treatments include complementary alternative medications (CAM), probiotics and peppermint oil are useful adjuncts but have not specifically been described in IBS-D/M. Evidence strongly supports psychotherapy in the treatment of IBS. Beyond over-the counter anti-diarrhoeals, anti-spasmodics and anti-depressants, pharmacological treatment now includes treating for bile acid malabsorption and the FDA-approved medications rifaximin, eluxadoline and alosetron. Conclusions: The treatment of IBS-D/M ideally involves a multidisciplinary approach of primary care, gastroenterologist and psychologist. Treatment often involves both non-pharmacological and pharmacological therapies. Future therapies may include faecal microbial transplant, Crofelemer and serotonin antagonists, but further studies are needed.

Current state of the non‐pharmacological management of irritable bowel syndrome: an up‐to‐date review of the literature

Review Article: Current and future treatment approaches for IBS with diarrhoea (IBS-D) and IBS mixed pattern (IBS-M)

Current Recommendations and Evidence

British Society of Gastroenterology guidelines on the management of irritable bowel syndrome

New drugs in the management of the irritable bowel syndrome

Irritable Bowel Syndrome: Treating the Gut and Brain/Mind at the Same Time

Irritable bowel syndrome: recent and novel therapeutic approaches

Current and novel therapeutic options for irritable bowel syndrome management

Irritable bowel syndrome: diagnosis and management

Dietary management of irritable bowel syndrome: considerations, challenges, and solutions

Diagnostic and therapeutic strategies in the irritable bowel syndrome

New developments in the treatment of irritable bowel syndrome

The Role of Food in the Treatment of Bowel Disorders: Focus on Irritable Bowel Syndrome and Functional Constipation

Potential Causes and Present Pharmacotherapy of Irritable Bowel Syndrome: An Overview

The Irritable Bowel Syndrome: Mechanisms and a Practical Approach to Management

Irritable bowel syndrome: treatment based on pathophysiology and biomarkers

[The proven and the new in the pharmacotherapy of irritable bowel syndrome]

Pharmacological and Non-Pharmacological Treatments for Irritable Bowel Syndrome

Managing irritable bowel syndrome: The impact of micro-physiotherapy

Gut-directed hypnosis and hypnotherapy for irritable bowel syndrome: a mini-review

The Microbiome and Irritable Bowel Syndrome – A Review on the Pathophysiology, Current Research and Future Therapy